Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Oncogenic Helicase ALC1 Regulates PARP Inhibitor Potency by Trapping PARP2 at DNA Breaks
Charlotte Blessing, Imke K. Mandemaker, Claudia Gonzalez-Leal, et al.
Molecular Cell (2020) Vol. 80, Iss. 5, pp. 862-875.e6
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Targeting DNA damage response pathways in cancer
Florian J. Groelly, Matthew Fawkes, Rebecca A. Dagg, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 2, pp. 78-94
Closed Access | Times Cited: 427
The expanding universe of PARP1-mediated molecular and therapeutic mechanisms
Dan Huang, W. Lee Kraus
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2315-2334
Open Access | Times Cited: 158
DNA repair defects in cancer and therapeutic opportunities
Jessica L. Hopkins, Li Lan, Lee Zou
Genes & Development (2022) Vol. 36, Iss. 5-6, pp. 278-293
Open Access | Times Cited: 118
Revolutionizing DNA repair research and cancer therapy with CRISPR–Cas screens
Samah W. Awwad, Almudena Serrano-Benítez, John C. Thomas, et al.
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 7, pp. 477-494
Closed Access | Times Cited: 48
Rapid Detection and Signaling of DNA Damage by PARP-1
Nootan Pandey, Ben E. Black
Trends in Biochemical Sciences (2021) Vol. 46, Iss. 9, pp. 744-757
Open Access | Times Cited: 88
The trans cell cycle effects of PARP inhibitors underlie their selectivity toward BRCA1/2-deficient cells
Antoine Simoneau, Rosalinda Xiong, Lee Zou
Genes & Development (2021) Vol. 35, Iss. 17-18, pp. 1271-1289
Open Access | Times Cited: 80
The CIP2A–TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer
Salomé Adam, Silvia Emma Rossi, Nathalie Moatti, et al.
Nature Cancer (2021) Vol. 2, Iss. 12, pp. 1357-1371
Closed Access | Times Cited: 76
Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand
Parasvi S. Patel, Arash Algouneh, Razqallah Hakem
Oncogene (2021) Vol. 40, Iss. 17, pp. 3001-3014
Closed Access | Times Cited: 65
Micropeptide PACMP inhibition elicits synthetic lethal effects by decreasing CtIP and poly(ADP-ribosyl)ation
Chuanchao Zhang, Bo Zhou, Feng Gu, et al.
Molecular Cell (2022) Vol. 82, Iss. 7, pp. 1297-1312.e8
Open Access | Times Cited: 57
PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites
Xiaohui Lin, Wenxia Jiang, Johannes Rudolph, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 7, pp. 3958-3973
Open Access | Times Cited: 41
The DNA damage response in the chromatin context: A coordinated process
Juliette Dabin, Margherita Mori, Sophie E. Polo
Current Opinion in Cell Biology (2023) Vol. 82, pp. 102176-102176
Open Access | Times Cited: 28
ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification
Élise Rouleau-Turcotte, John M. Pascal
Journal of Biological Chemistry (2023) Vol. 299, Iss. 12, pp. 105397-105397
Open Access | Times Cited: 22
BRCAness, DNA gaps, and gain and loss of PARP inhibitor–induced synthetic lethality
Xin Li, Lee Zou
Journal of Clinical Investigation (2024) Vol. 134, Iss. 14
Open Access | Times Cited: 13
A unified mechanism for PARP inhibitor-induced PARP1 chromatin retention at DNA damage sites in living cells
Petar-Bogomil Kanev, Sylvia Varhoshkova, Irina Georgieva, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114234-114234
Open Access | Times Cited: 10
The emerging determinants of replication fork stability
Tanay Thakar, George‐Lucian Moldovan
Nucleic Acids Research (2021) Vol. 49, Iss. 13, pp. 7224-7238
Open Access | Times Cited: 53
Tackling PARP inhibitor resistance
Kasper Fugger, Graeme Hewitt, Stephen C. West, et al.
Trends in cancer (2021) Vol. 7, Iss. 12, pp. 1102-1118
Closed Access | Times Cited: 42
Mechanisms of PARP1 inhibitor resistance and their implications for cancer treatment
Lindsey M. Jackson, George‐Lucian Moldovan
NAR Cancer (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 30
TSG101 associates with PARP1 and is essential for PARylation and DNA damage‐induced NF‐κB activation
Ahmet Buğra Tufan, Katina Lazarow, Marina Kolesnichenko, et al.
The EMBO Journal (2022) Vol. 41, Iss. 21
Open Access | Times Cited: 29
The APE2 nuclease is essential for DNA double-strand break repair by microhomology-mediated end joining
Hubert Fleury, Myles K. MacEachern, Clara M. Stiefel, et al.
Molecular Cell (2023) Vol. 83, Iss. 9, pp. 1429-1445.e8
Open Access | Times Cited: 18
Specific and shared biological functions of PARP2 – is PARP2 really a lil’ brother of PARP1?
Magdolna Szántó, José Yélamos, Péter Bai
Expert Reviews in Molecular Medicine (2024) Vol. 26
Open Access | Times Cited: 5
Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome
Luka Bačić, Guillaume Gaullier, Anton Sabantsev, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 33
DNA Double Strand Break Repair and Its Control by Nucleosome Remodeling
Leonhard Karl, Martina Peritore, Lorenzo Galanti, et al.
Frontiers in Genetics (2022) Vol. 12
Open Access | Times Cited: 25
Linking DNA repair and cell cycle progression through serine ADP-ribosylation of histones
Julien Brustel, Tetsuya Muramoto, Kazuki Fumimoto, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA
Kouji Hirota, Masato Ooka, Naoto Shimizu, et al.
Genes to Cells (2022) Vol. 27, Iss. 5, pp. 331-344
Open Access | Times Cited: 23
Reconsidering the mechanisms of action of PARP inhibitors based on clinical outcomes
Hiroshi Onji, Junko Murai
Cancer Science (2022) Vol. 113, Iss. 9, pp. 2943-2951
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top